Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Trading Statement

12 Oct 2007 07:00

Cyprotex PLC12 October 2007 Cyprotex PLC (the "Group" or "Cyprotex") NEWS 12 October 2007 Trading Update : Building Confidence The Director's confidence with Cyprotex's core operations continued to buildduring the third quarter of 2007. The Group enters the final three months ofits year on an optimistic note. Historically the final quarter has been the strongest period of Cyprotex'sfinancial year. Moreover, management is pleased to confirm that its customerbase has continued to expand rapidly. Included within the high number of newMSA (Master Services Agreements) recently signed, and taking the Group's 'activecustomer list' beyond 150 pharmaceutical and biotech companies, are severalinternational majors. Strict confidentiality agreements preclude Cyprotex fromnaming individual clients, but the company can now confirm it is currentlycontracted to work for six out of the world's 'top ten' global pharmaceuticalcompanies. The scale and visibility that strong working relationships with suchpartners are capable of providing, is key to proving Cyprotex's business plan.The management is pleased to report an exceptional level of repeat business,while also being asked to tenders for more long-term contract work as well asproject specific collaborations. Cyprotex presently holds an adequate cash resource whilst also retaining asignificant, unused banking facility. Based on current momentum, managementsees the opportunity for modest cash generation to expand this 'cushion' stillfurther during the final three months of the 2007. For further information: Cyprotex PLCRobert Morrison Atwater, CEORussell Gibbs, CFOTel: +44 (0)1625 505 100ir@cyprotex.comwww.cyprotex.com Numura Code Securities LimitedCharles Walker, Corporate FinanceTel: +44 (0)20 7776 1200cew@nomuracode.comwww.nomuracode.com Media Enquires: WMC CommunicationsSimon MillerTel: +44 (0)20 7930 9030simon.miller@wmccommunications.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Mar 20137:00 amRNSFinal Results
15th Mar 20137:00 amRNSNotice of Results
26th Feb 201312:05 pmRNSHolding(s) in Company
26th Feb 201312:05 pmRNSHolding(s) in Company
14th Feb 20137:00 amRNSLaunch of new cardiotoxicity service-eCiphrCardio
11th Jan 20137:00 amRNSIssue of Equity
13th Dec 20127:00 amRNSTrading Statement
30th Oct 20127:00 amRNSRe Agreement with Pfizer
29th Oct 20127:00 amRNSChange of NOMAD Name
16th Oct 20127:00 amRNSLicensing Agreement with Sigma Life Science
20th Sep 20127:00 amRNSCellCiphr Premier Launch
6th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSJoint Service Offering
4th Sep 20127:00 amRNSNotice of Results
4th Sep 20127:00 amRNSBoard Change
2nd Aug 20127:00 amRNSUpdated Regulatory Guidance Booklet
18th Jul 20121:49 pmRNSResult of AGM
21st Jun 20127:00 amRNSAlliance with Sirius Analytical
3rd May 20127:00 amRNSProduct Launch
22nd Mar 20127:00 amRNSFinal Results
12th Jan 20127:00 amRNSPre-Closed Trading Update
16th Dec 20117:00 amRNSSygnature Discovery and Cyprotex Extend Alliance
9th Nov 20117:00 amRNSProduct Upgrade
7th Nov 20117:00 amRNSExpansion of US Facility
29th Sep 20117:00 amRNSBoard Change
25th Aug 20117:00 amRNSHalf Yearly Report
8th Jul 20117:00 amRNSRe Agreement
30th Jun 20117:00 amRNSAGM Statement
23rd Mar 20117:00 amRNSFinal Results
11th Mar 201112:34 pmRNSRevised date for Results
1st Mar 201112:50 pmRNSNotice of Results
24th Dec 20107:00 amRNSTrading Statement
8th Nov 20104:53 pmRNSDirector/PDMR Shareholding
1st Nov 20107:00 amRNSAppointment of New Non-Executive Director
19th Oct 201010:07 amRNSProduct Update
12th Oct 20109:37 amRNSLaunches new transporter assay for BCRP
1st Oct 20107:00 amRNSCyprotex officially open new toxicology laboratory
16th Sep 20107:00 amRNSCyprotex and TB Alliance form collaboration
1st Sep 20107:00 amRNSProvides free online access to Cloe Knowledge
20th Aug 20107:00 amRNSCyprotex Adds In Vitro Toxicology Services
19th Aug 20109:30 amRNSHolding(s) in Company
18th Aug 20103:30 pmRNSHolding(s) in Company
18th Aug 20103:18 pmRNSHolding(s) in Company
18th Aug 20102:16 pmRNSDirector/PDMR Shareholding - amendment
18th Aug 20107:00 amRNSDirector/PDMR Shareholding
12th Aug 20107:00 amRNSHalf Yearly Report
6th Aug 20107:00 amRNSAcquisition of Apredica
14th Jul 20103:05 pmRNSResult of AGM
14th Jul 20107:00 amRNSAGM Statement
2nd Jul 20107:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.